mardi 29 septembre 2015

Onco Actu du 29 septembre 2015

3.1 Tabac

India delays implementation of bigger tobacco pack warnings [Reuters]

3.4.1 Chimioprévention - aspirine

Too soon for 'aspirin doubles cancer survival' claim [NHS Choices]

4.2 Dép., diag. & prono. - Génome

Sequencing Metastatic Cancers Could Lead to Improved Therapies [GEN]

4.9 Dép., diag. & prono. - Sein

Hologic Falls as Study Questions Computer-Aided Mammograms [Bloomberg]

Profiles in Science: A Breast Cancer Surgeon Who Keeps Challenging the Status Quo [NY Times]

Computer-aided mammography might not help spot breast cancer [Reuters]

5. Traitements

A better way to treat cancer: understanding tumors [Fortune]

5.12 Immunothérapies

"Fine Tuning" Engineered T Cells May Extend Immunotherapy Approach to More Cancer Types [National Cancer Institute]

5.2 Pharma

Roche wins kudos for game-changing atezolizumab cancer data [FierceBiotech]

Verastem Sinks as Mesothelioma Study Halted For Futility [Xconomy]

Verastem Takes a Tumble [In the Pipeline]

Verastem stops cancer therapy development; shares plunge [Reuters]

Cometriq plays wallflower as Opdivo’s dance card fills [EP Vantage]

5.2.1 Pharma - Partenariats

Sorrento launches another joint venture with a $170M cancer deal [FierceBiotech]

5.4 Traitements - Economie

Breast cancer treatment: Drug pertuzumab licensed [BBC News]

Why pharmaceuticals are cheaper abroad [CNN]

5.6.10 ESMO - Vessie

Bladder Cancer Treatment IMvigor-ated [The OBR Blog]

Lilly's CYRAMZA® (ramucirumab) Significantly Improves Progression-Free Survival in Phase II Bladder Cancer Trial [Lilly]

5.6.11 ESMO- Rein

Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients [MD Anderson Cancer Center]

CheckMate-025 and METEOR: The Overall Survival Barrier Has Finally Been Broken in RCC [The OBR Blog]

In A First, Kidney Cancer Drug Extends Survival [Forbes]

5.6.12 ESMO - Observation

Study: pregnant women with cancer can be treated without harming fetus [The Guardian]

Study Offers Support for Cancer Treatment During Pregnancy [NY Times]

Pregnant cancer patients shouldn't terminate or delay treatment: study [Reuters]

5.6.13 ESMO - Prostate

Fewer, larger radiotherapy doses prove effective for prostate cancer patients [Cancer Research UK]

5.6.2 ESMO - Divers

Global investment in cancer radiotherapy and surgery 'urgently needed' [Cancer Research UK]

Comprehensive Genomic Profiling Detects High Frequency of ERBB2 Extracellular Domain Mutations in Multiple Cancer Types [ESMO]

ESMO Commentary: Innovative approaches and drugs in early development phase show promising results in solid tumours [ESMO]

5.6.4 ESMO - Poumon

Seeing the Forest from the Trees: Atezolizumab in the Rapidly Shifting NSCLC Landscape [The OBR Blog]

Comprehensive Genomic Profiling of BRAF in a Large Series of Lung Cancer Samples [ESMO]

ESMO Commentary: Genomic landscape in lung cancer: steps forward in rapidly identifying genomic alterations [ESMO]

5.6.5 ESMO - Mélanome & Peau

ESMO Commentary: A new promise for a rare skin cancer [ESMO]

5.6.6 ESMO - Sein

Breast Cancer Gene Test Helps Predict Who Can Skip Chemo [NPR]

Early Tumors: Treating Breast Cancer Without Chemotherapy [Time]

ESMO Commentary: Preserving fertility in breast cancer patients: new promises [ESMO]

5.6.8 ESMO - Côlon-rectum

Response to EGFR Agents in Combination With Chemotherapy Demonstrated in Patients with Metastatic Colorectal Cancer of Rare KRAS Molecular Subtype [ESMO]

6.4 Médico-éco

Patients Are Seen as Potential Donors, Many Doctors Say [NY Times]

6.8 Communication

May I take your metaphor? – how we talk about cancer [Cancer Research UK]